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Abstract
Background: Embryonic lethality is a recognized phenotypic expression of individual gene mutations in model
organisms. However, identifying embryonic lethal genes in humans is challenging, especially when the phenotype
is manifested at the preimplantation stage.
Results: In an ongoing effort to exploit the highly consanguineous nature of the Saudi population to catalog
recessively acting embryonic lethal genes in humans, we have identified two families with a female-limited
infertility phenotype. Using autozygosity mapping and whole exome sequencing, we map this phenotype to a
single mutation in TLE6, a maternal effect gene that encodes a member of the subcortical maternal complex in
mammalian oocytes. Consistent with the published phenotype of mouse Tle6 mutants, embryos from female
patients who are homozygous for the TLE6 mutation fail to undergo early cleavage, with resulting sterility. The
human mutation abrogates TLE6 phosphorylation, a step that is reported to be critical for the PKA-mediated
progression of oocyte meiosis II. Furthermore, the TLE6 mutation impairs its binding to components of the
subcortical maternal complex.
Conclusion: In this first report of a human defect in a member of the subcortical maternal subcritical maternal
complex, we show that the TLE6 mutation is gender-specific and leads to the earliest known human embryonic
lethality phenotype.
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Background
Thousands of genes are known to exert specific pheno-
typic effects when mutated individually and are referred to
as ‘Mendelian’. The phenotypic consequences of muta-
tions in Mendelian genes involve virtually every known
aspect of human physiology and anatomy [1]. Embryonic
lethality sometimes represents the severe end of the
phenotypic expression of Mendelian genes that are other-
wise better known for their postnatal phenotypic conse-
quences [2]. On the other hand, embryonic lethality may
be the only phenotypic expression of genes that play a
fundamental role in early development [3]. Identifying
these genes, therefore, can provide novel insights into
basic biological processes during development [1, 4]. The
fraction of Mendelian genes in humans that are ‘embry-
onic lethal’ is unknown but extrapolation from model
organisms, for example, 19 % of yeast genes and 30 % of
mouse genes are embryonic lethal when knocked out,
suggests that they are at least in the hundreds [5, 6].
Consanguineous families facilitate the occurrence of
autosomal recessive Mendelian diseases by virtue of
rendering founder mutations homozygous through auto-
zygosity, and have greatly aided the discovery of novel
Mendelian genes through autozygosity mapping [7, 8].
More recently, combining autozygosity mapping with
genomic sequencing has markedly accelerated novel
disease gene discovery [9]. Due to practical reasons, the
entry phenotypes in these studies is almost always a
postnatal recognizable pattern rather than embryonic
lethality. We have recently shown that consanguineous
families that segregate embryonic lethal phenotypes
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provide an exceptionally high yield for novel gene dis-
covery where seven novel genes were identified from a
study of less than 20 families [3]. However, embryonic
lethality in that study was limited to late first trimester
and beyond, such that very early embryonic lethal events
could not be assessed. In this study, we report the
identification of the genetic cause of the earliest
known embryonic lethal phenotype through the study
of consanguineous families that segregate female-limited




Families were recruited through the Reproductive
Medicine Unit at KFSHRC based on the observation
of abnormal embryo development during regular in
vitro fertilization treatment of consanguineous cou-
ples. Eligible families and controls were enrolled after
signing a KFSHRC IRB-approved written informed
consent (RAC #2121053). Venous blood was collected
in EDTA and, when possible, in Na-heparin tubes for
DNA extraction and lymphoblastoid cell line estab-
lishment, respectively. All methods comply with the
Helsinki Declaration.
Autozygome and linakge analysis
Determination of the entire set of autozygous intervals
per genome (autozygome) was through genomewide
SNP genotyping (Axiom SNP chip, Affymetrix) followed
by mapping of runs of homozygosity as surrogates of
autozygosity using AutoSNPa v4, as described before
[10, 11]. Overlap in the autozygome of affected individuals
was employed as a strategy to determine the critical
disease locus. Statistical confirmation of the critical locus
was achieved by linkage analysis using easyLINKAGE [12].
Whole exome sequencing
Exome capture was performed using TruSeq Exome
Enrichment kit (Illumina) following the manufacturer’s
protocol. Samples were prepared as an Illumina sequen-
cing library, and in the second step, the sequencing
libraries were enriched for the desired target using the
Illumina Exome Enrichment protocol. The captured
libraries were sequenced using Illumina HiSeq 2000
Sequencer. The reads are mapped against UCSC hg19
[13] by BWA ver.0.5.9rc1 [14], without unordered se-
quences and alternate haplotypes. The Picard-tools suite
(ver.1.59) was then utilized to sort by mapping coordi-
nates, and BEDtools (ver. 2.15.0) filtered out any reads
not present in the targeted exonic regions. SNPs and
Indels were detected by SAMTOOLS ver.0.1.18 [15] and
annotated using ANNOVAR ver.Nov 2011 [16]. The
candidacy of the resulting variants was based on their
physical location within the autozygome of the affected
individual, their population frequency and predicted
effect on the protein as described before [9]. Data used
in this paper come from a small and well-defined family.
To protect the identity of individuals, these confidential
data are not publicly available.
Western blot and phosphorylation analysis
Epstein Barr Virus (EBV) transformed cell lines were
produced from three healthy donors (controls) and from
three individuals who are homozygous for the TLE6
S510Y mutation (patients, see below). Western blot ana-
lysis was performed as described [17]. Briefly, cells were
harvested by centrifugation and resuspended in lysis
buffer (20 mM Tris pH 7.5, 350 mM NaCl, 0.05 %
β-mercaptoethanol) supplemented with a protease
inhibitor cocktail. After sonication and centrifugation,
30 μg of total cell lysates were analyzed by SDS-
PAGE on 10 % acrylamide or on 8 % Phospho-tag
acrylamide gels (Wako, TX, USA), followed by transfer of
the proteins onto nitrocellulose membrane. After blocking
in 5 % milk in TBS-Tween, the membranes were incu-
bated with anti-TLE6, anti-KDHC3L/Ecat1 from (Abcam,
Cambridge, MA, USA) or anti-OOEP, anti-Flag and
anti-GAPDH from (Santa Cruz, CA, USA). After
washing, secondary reactions were carried out with
biotin conjugated secondary antibodies followed by
anti-avidin-HRP conjugated antibody. Signals were
visualized using an LAS 4000 mini (GE Healthcare,
UK) and quantified using ImageQuant software (GE
Healthcare, UK).
Phosphatase inhibitor treatment
A total of 30 μg of whole cell lysates from the two
control individuals were incubated with 40 μM of calf
intestine alkaline phosphatase (CIP) (Promega, Madison,
WI, USA) and equimolar amount of PKI (5–24), PKA
Inhibitor (Santa Cruz, CA, USA) in a reaction buffer
(50 mM Tris–HCl, pH 9.3; 1 mM MgCl2; 0.1 mM
ZnCl2; 1 mM spermidine). Extracts were then analyzed
by western blot analysis as described before [17].
Production of TLE6 S510Y protein
Mutant TLE6 S510Y was produced using the Stratagene
site-directed mutagenesis system (Stratagene, La Jolla,
CA, USA) according to manufacturer’s instructions;
using Flag tagged TLE6 plasmid (Origene, Rockville,
MD, USA). Primers used to generate the mutation are
sense: 5′-TCCTGAGCGTCAAGTTCT(A)CCCCTTTG
GCCAGTGGTG-3′ and anti-sense: 5′-AGGACTCGC
AGTTCAAGATGGGGAAACCGGTCACCAC-3. The
base change was from C to A, shown between
brackets. After verification of the mutation by sequencing,
control transformed lymphocytes were transfected with
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wild-type and mutant plasmids using lipofectamine
(Invitrogen, Waltham, MA, USA). Twenty-four hours
post transfection, total cell lysates were prepared and
analyzed by western blotting or immunoprecipitation.
Immunoprecipitation
Cell extracts were re-suspended in a buffer containing
50 mM Tris pH7.6, 150 mM or 500 mM NaCl, 1 mM
EDTA, 1%Triton X-100, 1 mM PMSF supplemented with
phosphatase and protease inhibitor cocktail (Sigma). A
total of 60 μg of total protein was incubated with Flag-IgG
sepharose beads (Sigma-Aldrich, St. Louis, MO, USA) or
Protein A dynabeads (Invitrogen, Waltham, MA, USA)
coupled to anti-OOEP antibody (Santa Cruz, CA, USA) or
control IgG in a pull-down buffer (50 mM HEPES pH 7.5,
1 mM EDTA, 150 mM NaCl, 10 % glycerol, 0.1 % Tween
20, 0.5 mM DTT, 1 mM PMSF, 2 μg/mL leupeptin, and
2 μg/mL pepstatin A). Extracts were incubated with the
beads for at least 2 h at 4 °C while mixing on a rotating
wheel. After collection of the supernatants, the beads were
washed with pull-down buffer and left as a 50 % slurry
after a final wash. After elution, proteins were loaded on
10 % SDS-PAGE gel and immunoblotting was performed
using the indicated antibodies.
In vitro phosphorylation
Wild-type and TLE6-S510Y proteins were expressed
in HEK293 and immunoprecipitated using anti-Flag
beads (Sigma-Aldrich, St. Louis, MO, USA). A total
of 20 μg of purified proteins was added to a standard
PKA mixture containing 20 mM Hepes (pH 7.5),
5 mM MgCl2, 1 mM unlabeled ATP, 1 mM 1,4-
dithiothreitol, 100 mM NaCl, and 1 mM [γ32P]ATP
(0.5 Ci/mmol- Perkin Elmer, Waltham, MA, USA),
with different amounts of PKA (Promega, Madison, WI,
USA) as indicated and incubated for 1 h at 37 °C.
Reactions were stopped by adding 20 μL of 2X Laemmli
sample buffer and proteins were separated by SDS-
PAGE electrophoresis followed by autoradiography and
immunoblotting.
Results
Identification of a preimplantation embryonic lethal
phenotype
Failure of in vitro fertilization (IVF) can be caused by a
multitude of factors. However, failure of fertilization
despite intracytoplasmic injection of apparently healthy
sperms in apparently healthy eggs is highly unusual. In
our last 20 years of experience with thousands of IVF
cycles, we have observed this pattern consistently only
in eight couples, two of whom were consanguineous and
available for recontacting. Family 1 consists of two sis-
ters who presented separately for treatment of primary
infertility. Each of the sisters had four intra-cytoplasmic
sperm injection (ICSI) cycles in another hospital with no
fertilization and were therefore referred to our hospital
(at ages 26 and 36 years, respectively) where they had a
total of five cycles, comprising the successful stimulation
and retrieval of 58 oocytes. Only three oocytes devel-
oped two pronuclei indicating normal fertilization. These
zygotes had developmental arrest at the one-, two-, and
four-cell stage. These two sisters have a number of sis-
ters and brothers who are healthy and fertile. Family 2
was also consanguineous and the index presented with
her husband at the age of 30 years for treatment of pri-
mary infertility. The pattern of IVF failure was similar to
that described in Family 1 and two ICSI cycles with total
19 oocytes injected resulted in no zygote formation.Be-
cause of the potential for identification pedigrees for
these two families are not shown in this paper.
Identification of a novel disease locus for early embryonic
lethality defined by TLE6 mutation
Although the phenotype in the three women is primarily
failure of zygote formation, the occasional formation of
zygotes that did not divide suggested that the phenotype
in these patients can be considered preimplantation em-
bryonic lethality. The observation of this phenotype only
in certain female members of each family suggests that
this phenotype is female-limited, perhaps due to a reces-
sive mutation of a maternal effect gene. To identify the
likely causal mutation we performed whole-exome se-
quencing in two of the three affected women and only
considered homozygous, coding/splicing variants within
the autozygome of each individual. Only one novel
variant remained after applying these filters in both
exomes, a homozygous substitution in TLE6 (transdu-
cin-like enhancer of split 6, OMIM ID: 612399;
NM_001143986.1:c.1529C > A:p.S510Y) (Fig. 1b, d).
Reassuringly, this variant was present in an autozygous
interval that is shared by the three females (chr19:
2712016–3918047, hg19) (Fig. 1c). The identical haplo-
type indicated the presence of a common ancestor,
consistent with the shared geographic location of the
two families. Furthermore, linkage analysis showed
that this haplotype is the only haplotype to achieve
genomewide significance with LOD of 4.17 (Additional
file 1: Figure S1).
This variant was confirmed by Sanger sequencing to
be homozygous in the three female patients. Consistent
with this mutation exerting a gender-limited phenotype,
we also had access to one fertile brother who was also
homozygous for this variant (Fig. 1a). This mutation was
only observed once in the heterozygous state in 615
in-house Saudi exomes (allele frequency <0.001) and
was absent in the 1000 Genomes and Exome Variant
Server databases. The affected residue appears to be uni-
versally conserved among mammalian TLE6 orthologs
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(Fig. 1e), and is present within a stretch of seven WD40
domain repeats, which dominate the protein’s C-terminus
(Fig. 1f).
TLE6 mutation causes impaired phosphorylation
The variant we identified in TLE6 is predicted to be
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Fig. 1 Two families with primary infertility link to a mutation in TLE6. a The two affected sisters from Family 1 were separately subjected to whole
exome sequencing following the indicated pipeline. Each sister was examined based only on her own regions of homozygosity (ROH), and the
only surviving variant was found common to both. b High density genotyping output for chromosome 19p (using AutoSNPa software [10]), with
red indicating heterozygosity and black homozygosity. The three affected women share an identical haplotype which encompasses 42 genes,
based on UCSC Human Genome Browser data. c DNA chromatogram of the TLE6 mutation, with a normal control sequence for comparison.
d TLE6 orthologues appear to be present only in mammals, wherein there is universal conservation of the affected serine residue (boxed).
Sequence data were acquired on NCBI-BLAST then collated using Multalin [28]. e Serine 510 is located within a cluster of WD40 domain repeats
that make up most of the protein’s C-terminal half
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on the Ensembl Variant Effect Predictor GRCh37, default
parameters), indicating its strong conservation across
species and the deleterious calculated effect of the given
amino acid substitution. Since TLE6 is known to be
phosphorylated by protein kinase A (PKA) [18] and since
the mutation replaces a serine residue, we hypothesized
that the missense mutation exerts its pathogenicity by
disturbing a potential phosphorylation site on TLE6.
Immunoblot analysis using three patient-derived lym-
phoblastoid cell lines, showed a single band instead of
the doublet pattern indicative of unphosphorylated and
phosphorylated forms of TLE6 that we observed in
controls [18] (Fig. 2a, b). Analysis of the extracts using
phospho affinity gels [19] enhanced the mobility shift
of the phosphorylated form of TLE6, which was de-
tected in control cells whereas phosphorylated TLE6
was markedly reduced (>90 %) in the patient lympho-
blastoid cells (Fig. 2a, b). To validate that the slower
migrating band corresponded to phosphorylated TLE6, we
treated controls and patients extracts with calf intestine al-
kaline phosphatase (CIP), a generic phosphatase enzyme,
and with the PKA specific inhibitor (PKI), and analyzed
TLE6 on a phosphor-tag gel. We detected a significant
reduction of the slow-migrating form of TLE6 after CIP
and PKI treatment of control cells (Fig. 2c, d). Patient cells
expressed very low levels of phosphorylated-TLE6, and
both CIP and PKI treatment minimally affected TLE6
phosphorylation, showing the specificity of the de-
phosphorylation assay (Fig. 2c, d). The residual signals
likely correspond to TLE6 phosphorylation by other
kinases. Together these results show impaired TLE6
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Fig. 2 Abrogation of TLE6 protein phosphorylation due to TLE6 missense mutation. a Western blot using phospho-tag acrylamide gels showing a
shift of phosphorylated TLE6 and significant reduction of phosphorylated TLE6 in patient lymphocytes compared to normal controls. GAPDH is
shown as loading control. b Quantification of A. c Phosphorylation of TLE6 is reduced in control lymphocytes treated with 40 μM calf intestine
phosphatase (CIP) and PKA inhibitor (PKI). d Quantification of C from two biological repeats and two technical repeats. e In vitro phosphorylation
of wild-type and S510Y TLE6 by PKA in the presence of [γ32P] followed by autoradiography and immunoblotting using anti-TLE6. f Quantification
of E from three independent repeats. Ctr: Control cells, P: Patient cells
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and indicate the role of PKA in regulating TLE6
phosphorylation.
To confirm that PKA significantly phosphorylates the
S510 site in TLE6, we performed in vitro kinase assays
with increasing concentrations of purified PKA, and
wild-type or mutant TLE6-S510Y in the presence of
[γ32P] ATP. PKA successfully phosphorylated wild-type
TLE6 (Fig. 2e, lanes 2–5) while mutant TLE6-S510Y had a
significantly lower phosphorylation (Fig. 2e, lanes 7–10).
The reduced phosphorylation of TLE6-S510Y by PKA was
also observed by immunoblotting (Fig. 2e, lower panel).
Thus, these results indicate that the TLE6 mutation at
S510 impairs its phosphorylation by PKA.
TLE6 mutation affects binding to SCMC proteins
We sought to assess the effect of the TLE6 mutation on
binding to SCMC proteins as this may provide a
potential mechanism for the observed infertility pheno-
type [20]. Since clinical materials from unsuccessful
ICSIs were unavailable, we tested the effect of the S510Y
mutation on the physical binding between TLE6 and
two members of the human SCMC (OOEP and
KDHC3L). We performed immunoprecipitation and
western blot analysis using patient-derived lymphoblas-
toid cells (endogenous interaction) as well as through
transfection experiments (interaction between overex-
pressed proteins). Patient cells showed a reduced
interaction between endogenous OOEP and TLE6
(Fig. 3a, b). Interestingly, the interaction with phosphory-
lated TLE6 was mostly diminished. Similarly, a reduced
interaction between KDHC3L and phospho-TLE6 was
also observed (Fig. 3c, d). To investigate whether
phosphorylation of S510 is required for TLE6 binding

















































































































































Fig. 3 The TLE6 mutation diminishes SCMC protein binding and complex formation. a Interaction of endogenous OOEP protein with TLE6 from
control and patients cells after immunoprecipitation with anti-OOEP and IgG antibody followed by immunoblotting. b Quantification of A from
two biological repeats and two technical repeats. c Interaction of endogenous KDHC3L protein with TLE6 from control and patient cells
after immunoprecipitation with anti-KDHC3L/Ecat1 and IgG antibody followed by immunoblotting. d Quantification of C from two independent
experiments. e Immunoprecipitation performed from HEK293 cells expressing wild-type or mutant TLE6 S510Y with anti-Flag beads followed by
immunoblotting, showing reduced binding of OOEP and KDHC3L to mutant TLE6. f Quantification of E from two independent repeats
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mutant TLE6 S510Y in cells and assessed the ratio of
phosphorylated and total TLE6 after immunoprecipi-
tation. Decreased binding of OOEP and KDHC3L to
mutant TLE6-S510Y was observed (Fig. 3e, f ) indicat-
ing that the TLE6 mutation affects the interaction be-
tween the SCMC components.
Discussion
Maternal genes play a critical role in the very early
stages of embryonic development because of the lag in
transcribing genes derived from the male pronucleus.
Although maternal effect genes are very well studied in
other model organisms, little is known about them in
mammalian oocytes due to practical limitations [21].
Recently, TLE6 was identified as an essential member of
the four-protein, murine SCMC along with MATER,
Filia, and FLOPED [22]. Mice that are knocked out for
Tle6 exhibit complete infertility that is female-specific,
which places TLE6 as one of the less than 30 maternal
effect genes identified to date in mammals [23]. In
sheep, expression of the four homologous proteins was
recently linked to oocyte development potential [24].
The phenotypic overlap between our patients with
TLE6 mutation and the corresponding mouse model is
noteworthy. Ovulation proceeds normally in Tle6 mu-
tants and the retrieved oocytes appear normal just as we
observed in our three patients. The infertility phenotype
in Tle6 mutants specifically involves the zygote stage
and beyond. While a comparable number of one-cell zy-
gotes was retrieved from Tle6 mutant females following
hormonal stimulation and natural mating, there was a
protracted delay in undergoing the first cleavage and the
few that did, succumbed to disintegration and never
formed morula, a phenotype similar to that observed in
the few zygotes from our patients with homozygous
TLE6 mutation. On the other hand, we note that zygote
formation, which appears to have occurred normally in
the mouse model, was severely impaired in the human
patients. The human homologues of the four SCMC
proteins (NLRP5, OOEP, KHDC3L and TLE6) share
39–46 % identity with their mouse counterparts [20],
so the mechanism for this difference may lie in
interspecies divergence. Nonetheless, these observa-
tions suggest that the phenotype is not caused by an
impaired receptor mediated sperm-egg physical inter-
action as shown for Juno mutants but rather a maternal
gene that exerts its effect after the introduction of the
sperm [25].
The mechanism through which TLE6 exerts its mater-
nal effect is not completely understood. Tle6−/− oocytes
lack the normal subcortical distribution of the SCMC
despite normal abundance of RNA from their compo-
nent genes, which clearly shows an essential role for
TLE6 in stabilizing this complex [23]. Indeed, the Tle6
mutant phenotype is very similar to that observed in
knockouts of the other SCMC components indicating
that stabilized SCMC is necessary for the very early
stages of embryonic development [22, 26, 27]. Interest-
ingly, this early developmental role of TLE6 was inde-
pendently discovered through a study that examined the
dynamic function of PKA in meiotic maturation of
mammalian oocytes [18]. Suppressing PKA resulted in
oocytes that were blocked in meiosis II and TLE6 was
found to be a major substrate of PKA in this process.
TLE6 phosphorylation occurs in a very narrow window
within meiosis II and when this was blocked, oocytes
failed to mature.
Our data, based on patient cells as well as the mutant
Flag-TLE6 plasmid, demonstrate that the S510Y muta-
tion results in markedly reduced phosphorylation of
TLE6 and that this phosphorylation is mostly catalyzed
by PKA. Mutant TLE6 also exhibits impaired binding
ability to at least two SCMC component proteins. Taken
together, these data reveal two, potentially related, pheno-
typic mechanisms: reduced potential for PKA-catalyzed
phosphorylation and reduced potential to bind SCMC.
Although it is unclear whether the patient phenotype is
due to the absence of phosphorylation of S510, or its sub-
stitution with tyrosine, we note that both PKA-catalyzed
phosphorylation and binding to SCMC have been pro-
posed in the literature to explain the critical role of mater-
nal TLE6 in supporting peri-implantation embryogenesis
[18, 20, 23]. Since serine is a canonical phosphorylation
site, it is difficult to separate the two roles and, in fact, our
data suggest they are related.
Conclusions
To the best of our knowledge, this is the first reported
mutation in an SCMC gene in humans. Our data suggest
that TLE6 mutations are a rare cause of human female-
limited infertility and represent the earliest known hu-
man embryonic lethality that is explicable by a single
gene mutation. Our ongoing analysis of embryonic lethal
phenotypes is likely to reveal additional novel genes and
contribute to the understanding of the fundamental bio-
logical processes that control early human development.
Additional file
Additional file 1: Figure S1. TLE6 is linked to a novel female-sterility
phenotype in humans. Genomewide linkage analysis using all available
family members from both study families shows that the only signifi-
cant linkage peak, that is, LOD >3 is the one corresponding to the
founder haplotype spanning TLE6 on chromosome 19. (PDF 44 kb)
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